Vice President, Innovations at Dana-Farber Cancer Institute

Emy Chen, PhD, is Vice President of Innovation at Dana-Farber Cancer Institute. She has oversight over the Innovations Licensing, Research Contracts, Compliance, and Finance functions of the Robert and Renee Belfer Office for Dana-Farber Innovations (BODFI). A primary focus for her role is to continuously refine and optimize the Innovation team's ability to provide excellent partnership and collaboration with clinicians and research scientists at Dana-Farber, and to catalyze and sustain relationships with external stakeholders in industry in order to bring new discoveries from the labs at Dana-Farber to patients. 

Prior to joining Dana-Farber, Emy was Director of Licensing at Mass General Brigham Innovation, where she spent 13 years supporting investigators and building relationships with biotech and pharma companies, primarily for innovators in the disciplines of medicine, neuroscience, and dermatology. Emy holds a PhD from Harvard University in Molecular and Cellular Biology, a BA from the University of California-Berkeley in Molecular and Cell Biology, and is a registered patent agent with the United States Patent and Trademark Office (USPTO).

Connect with Katie on LinkedIn